Clinical trial Recruiting at 3 sites Interventional Ages 18 and up Women only

Support for Just-In-Time Consent for Prenatal Screening

Official title: Supporting Just-In-Time Consent for Prenatal Screening: The INFORM Study

Run by Case Western Reserve University · NCT07557303 · Data updated 2026-11-12

This study tests a short set of information cards delivered on a phone to help pregnant people decide about prenatal screening.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment1400 (estimated)
SponsorCase Western Reserve University
Academic / other
Locations3 sites (San Francisco, California and 2 other locations)
StatusRecruiting
StartedSeptember 10, 2026
Main results expectedJune 30, 2028
Study endsJune 30, 2028
Registry record updatedSeptember 22, 2026
Trial IDNCT07557303 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant individuals up to 24 weeks gestation who are receiving care at UNC Chapel Hill, UCSF Benioff/ZSFG, or UF Health Jacksonville, and who can read or understand English or Spanish.

Probably not a fit

Individuals who do not choose or need prenatal screening, or who do not engage with the information cards, may not experience a benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants are pregnant individuals at select sites who will receive a mobile information intervention before their routine prenatal screening discussion. The study compares those who receive the intervention with those who do not, in addition to standard care. The goal is to see if the intervention increases confidence in decision-making about screening. Inclusion requires being 18 or older, able to read/speak English or Spanish, and up to 24 weeks gestation; participants must be at a collaborating site and have not yet been offered prenatal screening for the current pregnancy. The intervention focuses on noninvasive prenatal testing information and informed consent concepts.

Why it matters

Potential benefit: If successful, the intervention could help pregnant people feel more confident about their screening decisions.

How similar studies have gone: Previous approaches using patient-facing information aids have shown potential to support informed decision-making in prenatal care, but this exact just-in-time consent approach is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Currently pregnant and receiving care at a participating collaborative site - University of North Carolina, Chapel Hill; Zuckerberg Chan San Francisco General Hospital; University of Florida Health, Jacksonville.
* 18 years of age and older
* Able to read, speak, and understand English or Spanish
* Has not previously been offered prenatal genetic screening for the current pregnancy
* 24 weeks (6 months) gestational age or less

Exclusion Criteria:

* Not pregnant, not a patient at a partner clinical site
* Younger than 18 years of age
* Not being able to read, speak, and understand English or Spanish
* Has previously been offered prenatal genetic screening for the current pregnancy
* Greater than 24 weeks gestational age (6 months)

Where it's running

  • Zuckerberg Chan San Francisco General Hospital
    San Francisco, California, United States
    Recruiting
  • University of Florida Health
    Jacksonville, Florida, United States
    Recruiting
  • University of North Carolina
    Chapel Hill, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.